CompanyDrug

AbbVie’s Aquipta and Novartis’s Piqray Receive Regulatory Approvals in Mexico

R&D

Oxford and Peking University Study Unveils Genetic Risk Factors in East Asian Population

CompanyDeals

Roche and Alnylam Partner on RNAi Therapeutic Zilebesiran for Hypertension Treatment

CompanyDeals

Pfizer Ends Partnership with Syros Pharmaceuticals for Sickle Cell Disease Program

CompanyDrug

Ascletis Pharma’s ASC22 Combo Therapy Shows Promise in HIV Functional Cure Clinical Trial

CompanyDrug

Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group Get NMPA Approval for Solid Tumor Treatment

CompanyPolicy / Regulatory

Taiwan’s TFDA Orders Recall of Two Nucala Batches Due to Glass Fragments

CompanyDrug

Eli Lilly’s Mirikizumab and Chia Tai Tianqing’s Lanifibranor Enter Breakthrough Therapy Review

CompanyDeals

Amoy Diagnostics and AstraZeneca Expand Partnership for Companion Diagnostic Development

CompanyDrug

Vcanbio’s VUM02 Stem Cell Therapy Accepted for Review by China’s CDE for aGvHD Treatment

Medical DevicePolicy / Regulatory

NMPA Updates List of Medical Devices Exempt from Clinical Evaluation in China

Policy / Regulatory

Chinese Health Authorities Unveil Key Reform Tasks for Medical System in H2 2023